Global Generic Injection Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Generic Injection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Liquid Injection
  • 1.2.3 Powder for Injection
• 1.3 Market by Application
  • 1.3.1 Global Generic Injection Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Generic Injection Market Perspective (2016-2027)
• 2.2 Generic Injection Growth Trends by Regions
  • 2.2.1 Generic Injection Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Generic Injection Historic Market Share by Regions (2016-2021)
  • 2.2.3 Generic Injection Forecasted Market Size by Regions (2022-2027)
• 2.3 Generic Injection Industry Dynamic
  • 2.3.1 Generic Injection Market Trends
  • 2.3.2 Generic Injection Market Drivers
  • 2.3.3 Generic Injection Market Challenges
  • 2.3.4 Generic Injection Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Generic Injection Players by Revenue
  • 3.1.1 Global Top Generic Injection Players by Revenue (2016-2021)
  • 3.1.2 Global Generic Injection Revenue Market Share by Players (2016-2021)
• 3.2 Global Generic Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Generic Injection Revenue
• 3.4 Global Generic Injection Market Concentration Ratio
  • 3.4.1 Global Generic Injection Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Generic Injection Revenue in 2020
• 3.5 Generic Injection Key Players Head office and Area Served
• 3.6 Key Players Generic Injection Product Solution and Service
• 3.7 Date of Enter into Generic Injection Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Generic Injection Breakdown Data by Type

• 4.1 Global Generic Injection Historic Market Size by Type (2016-2021)
• 4.2 Global Generic Injection Forecasted Market Size by Type (2022-2027)

5 Generic Injection Breakdown Data by Application

• 5.1 Global Generic Injection Historic Market Size by Application (2016-2021)
• 5.2 Global Generic Injection Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Generic Injection Market Size (2016-2027)
• 6.2 North America Generic Injection Market Size by Type
  • 6.2.1 North America Generic Injection Market Size by Type (2016-2021)
  • 6.2.2 North America Generic Injection Market Size by Type (2022-2027)
  • 6.2.3 North America Generic Injection Market Size by Type (2016-2027)
• 6.3 North America Generic Injection Market Size by Application
  • 6.3.1 North America Generic Injection Market Size by Application (2016-2021)
  • 6.3.2 North America Generic Injection Market Size by Application (2022-2027)
  • 6.3.3 North America Generic Injection Market Size by Application (2016-2027)
• 6.4 North America Generic Injection Market Size by Country
  • 6.4.1 North America Generic Injection Market Size by Country (2016-2021)
  • 6.4.2 North America Generic Injection Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Generic Injection Market Size (2016-2027)
• 7.2 Europe Generic Injection Market Size by Type
  • 7.2.1 Europe Generic Injection Market Size by Type (2016-2021)
  • 7.2.2 Europe Generic Injection Market Size by Type (2022-2027)
  • 7.2.3 Europe Generic Injection Market Size by Type (2016-2027)
• 7.3 Europe Generic Injection Market Size by Application
  • 7.3.1 Europe Generic Injection Market Size by Application (2016-2021)
  • 7.3.2 Europe Generic Injection Market Size by Application (2022-2027)
  • 7.3.3 Europe Generic Injection Market Size by Application (2016-2027)
• 7.4 Europe Generic Injection Market Size by Country
  • 7.4.1 Europe Generic Injection Market Size by Country (2016-2021)
  • 7.4.2 Europe Generic Injection Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Generic Injection Market Size (2016-2027)
• 8.2 Asia-Pacific Generic Injection Market Size by Type
  • 8.2.1 Asia-Pacific Generic Injection Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Generic Injection Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Generic Injection Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Generic Injection Market Size by Application
  • 8.3.1 Asia-Pacific Generic Injection Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Generic Injection Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Generic Injection Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Generic Injection Market Size by Region
  • 8.4.1 Asia-Pacific Generic Injection Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Generic Injection Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Generic Injection Market Size (2016-2027)
• 9.2 Latin America Generic Injection Market Size by Type
  • 9.2.1 Latin America Generic Injection Market Size by Type (2016-2021)
  • 9.2.2 Latin America Generic Injection Market Size by Type (2022-2027)
  • 9.2.3 Latin America Generic Injection Market Size by Type (2016-2027)
• 9.3 Latin America Generic Injection Market Size by Application
  • 9.3.1 Latin America Generic Injection Market Size by Application (2016-2021)
  • 9.3.2 Latin America Generic Injection Market Size by Application (2022-2027)
  • 9.3.3 Latin America Generic Injection Market Size by Application (2016-2027)
• 9.4 Latin America Generic Injection Market Size by Country
  • 9.4.1 Latin America Generic Injection Market Size by Country (2016-2021)
  • 9.4.2 Latin America Generic Injection Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Generic Injection Market Size (2016-2027)
• 10.2 Middle East & Africa Generic Injection Market Size by Type
  • 10.2.1 Middle East & Africa Generic Injection Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Generic Injection Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Generic Injection Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Generic Injection Market Size by Application
  • 10.3.1 Middle East & Africa Generic Injection Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Generic Injection Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Generic Injection Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Generic Injection Market Size by Country
  • 10.4.1 Middle East & Africa Generic Injection Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Generic Injection Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Sanofi
  • 11.1.1 Sanofi Company Details
  • 11.1.2 Sanofi Business Overview
  • 11.1.3 Sanofi Generic Injection Introduction
  • 11.1.4 Sanofi Revenue in Generic Injection Business (2016-2021)
  • 11.1.5 Sanofi Recent Development
• 11.2 Fresenius
  • 11.2.1 Fresenius Company Details
  • 11.2.2 Fresenius Business Overview
  • 11.2.3 Fresenius Generic Injection Introduction
  • 11.2.4 Fresenius Revenue in Generic Injection Business (2016-2021)
  • 11.2.5 Fresenius Recent Development
• 11.3 Viatris
  • 11.3.1 Viatris Company Details
  • 11.3.2 Viatris Business Overview
  • 11.3.3 Viatris Generic Injection Introduction
  • 11.3.4 Viatris Revenue in Generic Injection Business (2016-2021)
  • 11.3.5 Viatris Recent Development
• 11.4 Pfizer
  • 11.4.1 Pfizer Company Details
  • 11.4.2 Pfizer Business Overview
  • 11.4.3 Pfizer Generic Injection Introduction
  • 11.4.4 Pfizer Revenue in Generic Injection Business (2016-2021)
  • 11.4.5 Pfizer Recent Development
• 11.5 Teva Pharmaceuticals
  • 11.5.1 Teva Pharmaceuticals Company Details
  • 11.5.2 Teva Pharmaceuticals Business Overview
  • 11.5.3 Teva Pharmaceuticals Generic Injection Introduction
  • 11.5.4 Teva Pharmaceuticals Revenue in Generic Injection Business (2016-2021)
  • 11.5.5 Teva Pharmaceuticals Recent Development
• 11.6 Hikma Pharmaceuticals
  • 11.6.1 Hikma Pharmaceuticals Company Details
  • 11.6.2 Hikma Pharmaceuticals Business Overview
  • 11.6.3 Hikma Pharmaceuticals Generic Injection Introduction
  • 11.6.4 Hikma Pharmaceuticals Revenue in Generic Injection Business (2016-2021)
  • 11.6.5 Hikma Pharmaceuticals Recent Development
• 11.7 Novartis
  • 11.7.1 Novartis Company Details
  • 11.7.2 Novartis Business Overview
  • 11.7.3 Novartis Generic Injection Introduction
  • 11.7.4 Novartis Revenue in Generic Injection Business (2016-2021)
  • 11.7.5 Novartis Recent Development
• 11.8 Amneal Pharmaceuticals
  • 11.8.1 Amneal Pharmaceuticals Company Details
  • 11.8.2 Amneal Pharmaceuticals Business Overview
  • 11.8.3 Amneal Pharmaceuticals Generic Injection Introduction
  • 11.8.4 Amneal Pharmaceuticals Revenue in Generic Injection Business (2016-2021)
  • 11.8.5 Amneal Pharmaceuticals Recent Development
• 11.9 Gland Pharma
  • 11.9.1 Gland Pharma Company Details
  • 11.9.2 Gland Pharma Business Overview
  • 11.9.3 Gland Pharma Generic Injection Introduction
  • 11.9.4 Gland Pharma Revenue in Generic Injection Business (2016-2021)
  • 11.9.5 Gland Pharma Recent Development
• 11.10 Allergan
  • 11.10.1 Allergan Company Details
  • 11.10.2 Allergan Business Overview
  • 11.10.3 Allergan Generic Injection Introduction
  • 11.10.4 Allergan Revenue in Generic Injection Business (2016-2021)
  • 11.10.5 Allergan Recent Development
• 11.11 Kelun Pharmaceutical
  • 11.11.1 Kelun Pharmaceutical Company Details
  • 11.11.2 Kelun Pharmaceutical Business Overview
  • 11.11.3 Kelun Pharmaceutical Generic Injection Introduction
  • 11.11.4 Kelun Pharmaceutical Revenue in Generic Injection Business (2016-2021)
  • 11.11.5 Kelun Pharmaceutical Recent Development
• 11.12 Jiangsu HRS
  • 11.12.1 Jiangsu HRS Company Details
  • 11.12.2 Jiangsu HRS Business Overview
  • 11.12.3 Jiangsu HRS Generic Injection Introduction
  • 11.12.4 Jiangsu HRS Revenue in Generic Injection Business (2016-2021)
  • 11.12.5 Jiangsu HRS Recent Development
• 11.13 Qilu Pharmaceutical
  • 11.13.1 Qilu Pharmaceutical Company Details
  • 11.13.2 Qilu Pharmaceutical Business Overview
  • 11.13.3 Qilu Pharmaceutical Generic Injection Introduction
  • 11.13.4 Qilu Pharmaceutical Revenue in Generic Injection Business (2016-2021)
  • 11.13.5 Qilu Pharmaceutical Recent Development
• 11.14 Chiatai Tianqing
  • 11.14.1 Chiatai Tianqing Company Details
  • 11.14.2 Chiatai Tianqing Business Overview
  • 11.14.3 Chiatai Tianqing Generic Injection Introduction
  • 11.14.4 Chiatai Tianqing Revenue in Generic Injection Business (2016-2021)
  • 11.14.5 Chiatai Tianqing Recent Development
• 11.15 Hainan Poly Pharm
  • 11.15.1 Hainan Poly Pharm Company Details
  • 11.15.2 Hainan Poly Pharm Business Overview
  • 11.15.3 Hainan Poly Pharm Generic Injection Introduction
  • 11.15.4 Hainan Poly Pharm Revenue in Generic Injection Business (2016-2021)
  • 11.15.5 Hainan Poly Pharm Recent Development
• 11.16 Yangzijiang Pharmaceutical Industry
  • 11.16.1 Yangzijiang Pharmaceutical Industry Company Details
  • 11.16.2 Yangzijiang Pharmaceutical Industry Business Overview
  • 11.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Introduction
  • 11.16.4 Yangzijiang Pharmaceutical Industry Revenue in Generic Injection Business (2016-2021)
  • 11.16.5 Yangzijiang Pharmaceutical Industry Recent Development
• 11.17 Shijiazhuang Pharma Group
  • 11.17.1 Shijiazhuang Pharma Group Company Details
  • 11.17.2 Shijiazhuang Pharma Group Business Overview
  • 11.17.3 Shijiazhuang Pharma Group Generic Injection Introduction
  • 11.17.4 Shijiazhuang Pharma Group Revenue in Generic Injection Business (2016-2021)
  • 11.17.5 Shijiazhuang Pharma Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer